Director/PDMR Shareholding

RNS Number : 4524P

GlaxoSmithKline PLC

03 October 2011

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 30 September 2011, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £13.40 per Ordinary share and $41.61 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2011 to 30 September 2011:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2,518.657
Prof. Sir Roy Anderson	489.739
		498.315
Dr Stephanie Burns
Ms Stacey Cartwright	349.813
Mr Lawrence Culp		996.629
Sir Crispin Davis	1,772.388
Ms Judy Lewent		249.157
Sir Deryck Maughan		711.878
Mr James Murdoch	1,399.254
Dr Daniel Podolsky		961.036
Mr Tom de Swaan	722.948
Sir Robert Wilson	489.739

The Company and the Non-Executive Directors were informed of these allocations on 3 October 2011.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 October 2011

 

END

 

 

RDSZXLFBFBFZFBK